WOLVERINE ASSET MANAGEMENT LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 83 filers reported holding REPROS THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$51,000
+6.2%
5,335
+55.3%
0.00%0.0%
Q3 2014$48,0003,435
+85775.0%
0.00%
Q2 2014$0
-100.0%
4
-99.0%
0.00%
Q1 2014$9,000
-10.0%
416
-2.1%
0.00%
Q4 2013$10,000
-28.6%
425
+29.2%
0.00%
Q3 2013$14,000
-94.8%
329
-97.6%
0.00%
-100.0%
Q2 2013$269,00013,7100.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders